Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 1268454-23-4, Mln1117, Mln-1117, Ink1117, Ink-1117, Agn-pc-0db6fl
Molecular Formula
C19H17N5O3
Molecular Weight
363.4  g/mol
InChI Key
BLGWHBSBBJNKJO-UHFFFAOYSA-N
FDA UNII
43J9Q56T3W

an investigational PI3Kalpha-selective inhibitor
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone
2.1.2 InChI
InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22)
2.1.3 InChI Key
BLGWHBSBBJNKJO-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
43J9Q56T3W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)(4-morpholinyl)methanone

2. Tak-117

3. Ink1117

4. Mln1117

2.3.2 Depositor-Supplied Synonyms

1. 1268454-23-4

2. Mln1117

3. Mln-1117

4. Ink1117

5. Ink-1117

6. Agn-pc-0db6fl

7. Tak-117

8. [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone

9. Methanone, [6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinyl-

10. 43j9q56t3w

11. 5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine

12. (6-(2-amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinylmethanone

13. Methanone, (6-(2-amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinyl-

14. (6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)(4-morpholinyl)methanone

15. Serabelisibum

16. (6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)-morpholin-4-ylmethanone

17. [6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinylmethanone

18. 5-(3-(morpholine-4-carbonyl)imidazo(1,2-a)pyridin-6-yl)-1,3-benzoxazol-2-amine

19. Refchem:182491

20. Tak 117

21. (6-(2-aminobenzo[d]oxazol-5-yl)imidazo[1,2-a]pyridin-3-yl)(morpholino)methanone

22. Serabelisib [inn]

23. Mfcd15146372

24. Mln 1117

25. [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholino-methanone

26. [6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinyl-methanone

27. Unii-43j9q56t3w

28. C19h17n5o3

29. Serabelisib [who-dd]

30. Gtpl8969

31. Orb1304485

32. Chembl3935857

33. Schembl12928418

34. Schembl29382156

35. Bdbm119531

36. Ex-a1112

37. Ink 1117

38. Mln1117; Ink1117

39. Nsc795384

40. S8581

41. Akos030526373

42. Ccg-268203

43. Cs-5490

44. Db14935

45. Ebc-520105

46. Nsc-795384

47. 1428967-74-1

48. Ac-33667

49. As-73722

50. Hy-12285

51. Db-084944

52. Ink-1117,mln-1117,tak-117

53. Serabelisib(tak-117,ink1117,mln1117)

54. Serabelisib(tak-117,ink1117,mln1117)?

55. Us9682141, 54

56. Serabelisib (ink-1117,mln-1117,tak-117)

57. Us9682141, 529

58. Brd-k73877023-001-01-9

59. Q27078071

2.4 Create Date
2013-03-21
3 Chemical and Physical Properties
Molecular Weight 363.4 g/mol
Molecular Formula C19H17N5O3
XLogP32.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area98.9
Heavy Atom Count27
Formal Charge0
Complexity557
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.